AlzeCure Publishes its Interim Report for January – September 2024

November 11, 2024 2:20 AM

STOCKHOLM, SE / ACCESSWIRE / November 11, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR) today announced that its interim report for the period January - September 2024 is now available on the company's website: www.alzecurepharma.com/en/section/investors/financial-reports/"The third quarter of 2024 was yet another positive and eventful quarter for AlzeCure Pharma. During the quarter, we published and...

Read more

Hemogenyx Pharmaceuticals PLC Announces Institutional Investment

November 11, 2024 2:00 AM

Hemogenyx Pharmaceuticals plc ("Hemogenyx Pharmaceuticals" or the "Company")(LSE:HEMO), the biopharmaceutical group focused on developing new therapies for blood diseases, is pleased to announce that it was approached by an institutional investor and that this investor has subscribed £600,000, for the issue of 60,000,000 new Ordinary Shares at 1p per share.The net proceeds of this subscription will be dedicated to the imminent commencement of...

Read more

Angle PLC Announces Parsortix enriched CTC & ctDNA in NSCLC patients

November 11, 2024 2:00 AM

ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology, is pleased to announce the publication of research investigating the dual analysis of CTCs and circulating tumour DNA (ctDNA) in non-small cell lung cancer (NSCLC), undertaken by the National and Kapodistrian University of Athens.Researchers used the...

Read more

Cantargia Results Showing Efficacy of CAN10 in Models of Myocarditis Published in Circulation: Heart Failure

November 11, 2024 2:00 AM

LUND, SWEDEN / ACCESSWIRE / November 11, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm:CANTA) today announced the publication of CAN10 results in disease models of myocarditis in the scientific journal Circulation: Heart Failure. Key results relate to strong treatment effects in both viral as well as autoimmune myocarditis. CAN10, simultaneously targeting IL-1, IL-33 and IL-36, generated much stronger effects than...

Read more

Relief Therapeutics Announces Positive Final Results of RLF-TD011 Clinical Trial in Epidermolysis Bullosa

November 11, 2024 1:20 AM

RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, today announced positive final results from its proof-of-concept, investigator-initiated clinical trial evaluating RLF-TD011 for the treatment of epidermolysis bullosa (EB), a rare genetic condition characterized by fragile skin...

Read more

Justera Health Announces RSU Grant

November 8, 2024 4:30 PM

Justera Health Ltd. (CSE:VTAL)(OTC PINK:SCRSF) ("Justera" or the "Company") is pleased to announce that its Board of Directors has approved the issuance of 23,000,000 restricted share units ("RSUs") under the Company's omnibus incentive plan (the "Plan") on November 7, 2024. These RSUs have been awarded to employees, directors, and consultants of the Company as part of a strategy to retain skilled personnel and align their interests with those...

Read more

Black Book Survey Reveals Key Concerns Hospital Administrators & Boards Have About Generative AI Integration

November 8, 2024 2:00 PM

Industry Leaders Call for AI Vendors to Address Critical Gaps in Solutions Before Pitching to Health SystemsTAMPA, FL / ACCESSWIRE / November 8, 2024 / As the healthcare industry grapples with the influx of generative AI solutions, hospital administrators are raising red flags over significant challenges associated with AI integration. In an ad hoc survey conducted by Black Book Market Research during the last weeks of October 2024, 185 hospital...

Read more

Jim Chao, CEO of Confidence USA, Featured in Exclusive Online Interview on Leadership and Innovation in Nutraceuticals

November 8, 2024 1:15 PM

Jim Chao, CEO of Confidence USA, Inc., a leading nutraceutical company, was recently featured in an exclusive online interview, offering in-depth insights into his journey and approach to leading one of the most innovative companies in the health and wellness sector. Since 2008, Chao has been at the forefront of Confidence USA's growth, merging traditional Eastern herbal wisdom with modern Western scientific advancements to create highly...

Read more

Fusion Listens to Healthcare Professionals, Launching Mobile App in Response to Expressed Needs

November 8, 2024 12:00 PM

As the country is in the midst of a clinician shortage, Fusion has launched an app that will help connect travel healthcare professionals to facilities across the country needing help.OMAHA, NE / ACCESSWIRE / November 8, 2024 / Traveling healthcare professionals working with Fusion Medical Staffing are now able to navigate their careers with the help of a mobile app. The Omaha-based healthcare company launched the app after listening to...

Read more

Global Microscope Digital Camera Market Poised for Strong Growth USD 2,132.7 million by 2034, Driven by Demand in Medical Diagnostics | Future Market Insights, Inc.

November 8, 2024 9:00 AM

The global microscope digital camera market is projected to grow at a robust 9.1% CAGR, reaching an impressive revenue of USD 2,132.7 million by 2034, up from USD 892.6 million in 2024. This growth is fueled by a rising demand for timely detection and preventive care, particularly in the medical field.A significant factor contributing to this market surge is the increased focus on early diagnosis and intervention in chronic and life-threatening...

Read more

Medholdings Groups Subsidiary Company Medsmart Wellness Centers is Proud to Announce Acquiring the Latest Technological Advances in Anti-Aging

November 8, 2024 8:30 AM

Med Holdings Group Inc. (OTC PINK:YUKA) is thrilled to announce its partnership with Aesthetic Partners, marking a transformative step in the future of longevity medicine. This collaboration has brought cutting-edge technology to the forefront of the MedSmart Wellness Centers - a premier network of medical spas specializing in advanced anti-aging therapies.Medsmart wellnessMedsmart About Aesthetic PartnersAesthetic Partners (AP) brings the...

Read more

Registration Is Now Open For Tribe Public's Webinar Event "Tailoring GLP-1 Weight Loss Treatments: Innovative Approaches To Personalized Dosing" Featuring Modular Medical CEO On Monday, November 11, 2024

November 8, 2024 8:00 AM

Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a development-stage, insulin delivery technology company seeking to launch the next generation of user-friendly and affordable insulin pump technology, today announced that Jeb Besser, CEO, will present at Tribe Public's Webinar Presentation and Q&A Event titled "Tailoring GLP-1 Weight Loss Treatments: Innovative Approaches To Personalized Dosing." The event is scheduled...

Read more

Ainos Takes Decisive Action to Protect Stockholder Interests and Combat Potential Illegal Trading Activities

November 8, 2024 8:00 AM

Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), an innovative healthcare company focused on advanced AI-powered point-of-care testing (POCT) and low-dose interferon therapeutics, today announced it has filed complaints with NASDAQ MarketWatch and the U.S. Securities and Exchange Commission (SEC), due to concerns about unusual trading activity in its common stock, specifically large-volume sell orders. Ainos suspects that...

Read more

Moderna Receives Health Canada Approval for RSV Vaccine for Adults Aged 60 Years and Older

November 8, 2024 7:30 AM

mRESVIA is Moderna's second approved product in Canada, the first mRNA vaccine against RSV, and the only one in single-dose pre-filled syringesCanada is the fourth jurisdiction to approve mRESVIA following approvals in the U.S., Europe, and QatarCAMBRIDGE, MA / ACCESSWIRE / November 8, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced Health Canada has approved mRESVIA™ (Respiratory Syncytial Virus mRNA vaccine) for active immunization for the...

Read more

Zomedica to Present at the Sidoti Micro Cap Conference November 14, 2024

November 8, 2024 6:30 AM

ANN ARBOR, MI / ACCESSWIRE / November 8, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced that Larry Heaton, Chief Executive Officer, will present and host one-on-one meetings with investors at the Sidoti Micro Cap Conference, taking place on November 13-14, 2024.The presentation will...

Read more

TMC Life Sciences Berhad Prioritises Patient-Centered Growth at 22nd AGM

November 7, 2024 10:30 PM

PETALING JAYA, SELANGOR, MALAYSIA / ACCESSWIRE / November 7, 2024 / TMC Life Sciences Berhad (TMCLS), a leading player in the healthcare industry, is poised for significant growth in the financial year ending 30 June 2024 (FY24), focusing on enhancing services for women and children. [L-R] Dr. Siva Kumaran Jayaraman, Acting Chief Executive Officer of Thomson Hospital Kota Damansara, Dr. Heng Jun Li Melvin, Acting Group Chief Executive Officer...

Read more

New Horizons Medical and Lawrence Medical Center Unite, Expanding Patient Care and Community Impact Across Massachusetts

November 7, 2024 4:59 PM

New Horizons Medical is excited to announce a new chapter in its journey, joining forces with Lawrence Medical Center under a strategic acquisition led by Lawrence Medical Center's CEO, Zoser Mohamed, and VP Mario DiPaola. This partnership integrates New Horizons Medical's six clinic locations and mobile clinic into the expanded Lawrence Medical Center network, creating an organization dedicated to high standards in patient care and community...

Read more

Zomedica Announces Third Quarter 2024 Financial Results: Revenue Up 10% to $7 Million; 72% Gross Margin, and $78 Million in Liquidity to Support Growth

November 7, 2024 4:25 PM

Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, today reported consolidated financial results for the third quarter ended September 30, 2024."We are very pleased with our performance, highlighted by record third quarter revenue and a double-digit increase compared to last year, which demonstrates that the...

Read more

Avinger Reports Third Quarter 2024 Results

November 7, 2024 4:05 PM

Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular disease, today reported results for the third quarter ended September 30, 2024.Third Quarter and Recent HighlightsReported third quarter 2024 revenue of $1.7 million, sequentially increased gross margin to 26%.Implemented cost reduction...

Read more

Protagonist Reports Third Quarter 2024 Financial Results and Provides Corporate Update

November 7, 2024 4:05 PM

Top line results for JNJ-2113 Phase 3 ICONIC-LEAD and Phase 3 ICONIC-TOTAL clinical trials in patients with moderate to severe psoriasis expected in Q4 2024Top line results for JNJ-2113 Phase 2b ANTHEM clinical trial in moderate to severe ulcerative colitis expected in Q1 2025Top line results for rusfertide Phase 3 VERIFY clinical trial in polycythemia vera expected in Q1 2025Development candidate nomination for oral IL-17 peptide antagonist...

Read more